Abstract Details
|
Erica S. Westphal
(Dent Neurologic Institute)
PRESENTER |
The institution of Ms. Westphal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson Coorporation. The institution of Ms. Westphal has received research support from Dent Neurologic Institute. |
| Michelle Rainka, PharmD (Dent Neurologic Institute) | Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes. |
| No disclosure on file | |
| Traci Aladeen, PharmD (Dent Neurologic Institute) | Dr. Aladeen has nothing to disclose. |
| Vernice E. Bates, MD (Dent Neurologic Institute) | No disclosure on file |
| Francis M. Gengo, PharmD (Dent Neurologic Institute) | No disclosure on file |